These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 28396115

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D, Gao P, Lee SF, Heinze G, Clase CM, Tobe S, Teo KK, Gerstein H, Mann JF, Oberbauer R, ONTARGET and ORIGIN Investigators.
    Clin J Am Soc Nephrol; 2015 Aug 07; 10(8):1371-9. PubMed ID: 26175542
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
    van den Born JC, Frenay AR, Bakker SJ, Pasch A, Hillebrands JL, Lambers Heerspink HJ, van Goor H.
    Nitric Oxide; 2016 May 01; 55-56():18-24. PubMed ID: 26952289
    [Abstract] [Full Text] [Related]

  • 13. Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?
    Weldegiorgis M, de Zeeuw D, Dwyer JP, Mol P, Heerspink HJL.
    Clin J Am Soc Nephrol; 2017 Oct 06; 12(10):1595-1600. PubMed ID: 28923834
    [Abstract] [Full Text] [Related]

  • 14. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.
    Skupien J, Warram JH, Smiles AM, Niewczas MA, Gohda T, Pezzolesi MG, Cantarovich D, Stanton R, Krolewski AS.
    Kidney Int; 2012 Sep 06; 82(5):589-97. PubMed ID: 22622493
    [Abstract] [Full Text] [Related]

  • 15. Clinical update: The important role of dual kidney function testing (ACR and eGFR) in primary care: Identification of risk and management in type 2 diabetes.
    Seidu S, Barrat J, Khunti K.
    Prim Care Diabetes; 2020 Aug 06; 14(4):370-375. PubMed ID: 32139245
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
    Panduru NM, Saraheimo M, Forsblom C, Thorn LM, Gordin D, Wadén J, Tolonen N, Bierhaus A, Humpert PM, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2015 May 06; 38(5):883-90. PubMed ID: 25720601
    [Abstract] [Full Text] [Related]

  • 18. Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits.
    Oellgaard J, Gæde P, Rossing P, Persson F, Parving HH, Pedersen O.
    Kidney Int; 2017 Apr 06; 91(4):982-988. PubMed ID: 28187983
    [Abstract] [Full Text] [Related]

  • 19. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
    Gu L, Huang L, Wu H, Lou Q, Bian R.
    Diab Vasc Dis Res; 2017 May 06; 14(3):221-225. PubMed ID: 28183204
    [Abstract] [Full Text] [Related]

  • 20. Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease.
    Kim SJ, Smail N, Paraskevas S, Schiff J, Cantarovich M.
    Transplantation; 2014 Mar 27; 97(6):675-80. PubMed ID: 24637866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.